Maximize Your Success in Decentralized Trials with SphygmoCor® Technology
actor_video_thumb2

As presented live at the DIA 2022 Global Annual Meeting in Chicago, Illinois

Central Blood Pressure Can Effectively Predict Cardiovascular Risk!
Dr_Hunter_Champion_newlogo_R

Cardiologist Dr. Hunter Champion uses SphygmoCor® XCEL to target medications and optimize hypertension care

What's new in Central Blood Pressure?
 
 
The only cure for dementia is prevention.

 
SphygmoCor® by the numbers

All “Top 20 Hospitals” use SphygmoCor® technology to measure central blood pressure (cBP)



4,000+ studies using the SphygmoCor® technology have been published in peer-reviewed clinical publications.


8 out of Top 10 Pharma companies have used SphygmoCor® technology in their clinical trials



Over 11,000 patients have been tested with SphygmoCor® technology in pharmaceutical trials


CLINICAL TRIAL AND RESEARCH PARTNERS